BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 12, 2013
View Archived Issues
Researchers at Apotex present new thymodepressin prodrugs
Read More
Biogen Idec and Isis Pharmaceuticals form collaboration for neurological disorders
Read More
Cellceutix acquires substantially all PolyMedix assets
Read More
NovelMed receives NIH grant to advance development of anti-complement antibody
Read More
Experimental pulmonary arterial hypertension inhibited by APT-102
Read More
CRAC channel inhibitor RP-3128 demonstrates anti-asthmatic activity
Read More
New adenovirus-based vaccines presented by researchers at McMaster University
Read More
Noscira discloses novel GSK-3 inhibitors
Read More
Swedish Orphan Biovitrum patents new C5 polypeptides
Read More
MicroConstants China in-licenses phase II liver cancer drug
Read More
Immunovaccine vaccines protect animals against anthrax challenge
Read More
Researchers at AbbVie design novel Wee1A kinase inhibitors
Read More
BioMotiv and NYU form new company, Orca Pharmaceuticals
Read More
Mitsubishi Tanabe Pharma reports the discovery and characterization of novel SGLT2 inhibitors
Read More
LTT-Bio Pharma announces changes to pipeline
Read More
Nuclea Biotechnologies acquires Wilex
Read More
Boehringer Ingelheim completes enrollment in phase IIa interferon-free HCV trial
Read More
Lundbeck reveals novel NK-3 receptor antagonists
Read More
New MGAT2 inhibitors for the treatment of metabolic syndrome presented
Read More
Alcobra reports preclinical data for MG-01CI in mouse model of fragile X syndrome
Read More
Omeros submits MAA to EMA for OMS-302
Read More
EMA grants orphan drug designation to Patrys antibody for multiple myeloma
Read More
First biosimilar monoclonal antibody approved in Europe
Read More
Eisai launches anticancer agent Halaven in Russia
Read More
Gilead files NDA for idelalisib in treatment of indolent non-Hodgkin's lymphoma
Read More
FDA accepts resubmission of NDA for oral treprostinil
Read More
FDA advisory committee recommends approval of umeclidinium/vilanterol for treatment of COPD
Read More